The Independent Pharmaceutical Network Alphega Pharmacy has presented the results of its 'Diabetes Month' campaign that, according to the organizers, concluded “successfully thanks to the large participation index among patients”, in a campaign designed with theObjective of sensitizing the population about the importance of the early diagnosis of this disease and preventing it from its symptoms and consequences.
10 Alphega Farmacia Imun Total of 200 pharmacies members of the Alphega Network throughout Spain performed the Findrisk test to patients who wanted it.Alphega informs that “this test consists of eight questions and is endorsed by the World Health Organization (WHO) and the International Diabetes Federation (IDF), among others, since it has an accuracy of up to 85% to thetime to detect the risk of development of type 2 diabetes in the next 10 years. ”
The results obtained during the campaign indicate that 21 percent of tested patients have a very low risk of developing type 2 diabetes over the next ten years and 33 percent suffer a moderate risk.On the other hand, 40 percent of respondents should take preventive measures, since the results of the tests suggest that they may suffer risk of developing the disease in the next decade;In approximately half of these cases, the risk is very high.
As the pharmaceutical network details, “thanks to this campaign carried out by Alphega Pharmacy, 190 patients have been detected with a risk of more than 50% of suffering from type 2 diabetes or who already suffered without knowing it, which were referred to thedoctor.In addition to the Findrisk test, more than 600 glucose tests were performed.Thanks to them, cases of asymptomatic diabetes were also detected. ”
